These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34288452)

  • 1. Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants.
    Gosselin RC
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():109-116. PubMed ID: 34288452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of coagulation test results under direct oral anticoagulants.
    Mani H
    Int J Lab Hematol; 2014 Jun; 36(3):261-8. PubMed ID: 24750672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory coagulation tests in patients treated by direct oral anticoagulants (DOACs)].
    Sié P
    Presse Med; 2015; 44(7-8):772-8. PubMed ID: 26248706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-Care Coagulation Tests Monitoring of Direct Oral Anticoagulants and Their Reversal Therapy: State of the Art.
    Iapichino GE; Bianchi P; Ranucci M; Baryshnikova E
    Semin Thromb Hemost; 2017 Jun; 43(4):423-432. PubMed ID: 28346965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preanalytical Variables in Hemostasis Testing.
    Gosselin RC
    Methods Mol Biol; 2023; 2663():39-50. PubMed ID: 37204702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Laboratory control of oral anticoagulants.
    Lancet; 1975 Feb; 1(7902):317-8. PubMed ID: 46454
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
    Santoro RC; Molinari AC; Leotta M; Martini T
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing and Reversing the Effect of Direct Oral Anticoagulants on Coagulation.
    Langer A; Connors JM
    Anesthesiology; 2020 Jul; 133(1):223-232. PubMed ID: 32217870
    [No Abstract]   [Full Text] [Related]  

  • 9. A Practical Guide to Ordering and Interpreting Coagulation Tests for Patients on Direct Oral Anticoagulants in Singapore.
    Wong WH; Yip CY; Sum CL; Tan CW; Lee LH; Yap ES; Kuperan P; Ting WC; Ng HJ
    Ann Acad Med Singap; 2016 Mar; 45(3):98-105. PubMed ID: 27146462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and citrate additive carryover during blood collection.
    Keppel MH; Auer S; Lippi G; von Meyer A; Cornes M; Felder TK; Oberkofler H; Mrazek C; Haschke-Becher E; Cadamuro J
    Clin Chem Lab Med; 2019 Nov; 57(12):1888-1896. PubMed ID: 31377734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy.
    van Geest-Daalderop JH; Mulder AB; Boonman-de Winter LJ; Hoekstra MM; van den Besselaar AM
    Clin Chem; 2005 Mar; 51(3):561-8. PubMed ID: 15650035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues.
    Tripodi A; Braham S; Scimeca B; Moia M; Peyvandi F
    Pol Arch Intern Med; 2018 Jun; 128(6):379-385. PubMed ID: 29968697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ; Mohammed S; Curnow J; Pasalic L
    Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do new oral anticoagulants require laboratory monitoring? The clinician point of view.
    Samama MM; Guinet C; Le Flem L
    Thromb Res; 2012 Oct; 130 Suppl 1():S88-9. PubMed ID: 23026675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of anticoagulants on coagulation testing.
    van de Kerkhof D; Schmitz E; Moolenaar M; Schellings M; Boer AK; Boonen K
    Clin Chem Lab Med; 2016 Jul; 54(7):e207-10. PubMed ID: 26824980
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting coagulation mixing study results in the era of direct oral anticoagulants.
    Kim MJ; Salazar E; Philips B; Rice L; Castillo B; Leveque C; Chen J
    Blood Coagul Fibrinolysis; 2024 Jan; 35(1):23-26. PubMed ID: 37994629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the main coagulation tests in the presence of hemolysis in healthy subjects and patients on oral anticoagulant therapy.
    D'Angelo G; Villa C; Tamborini A; Villa S
    Int J Lab Hematol; 2015 Dec; 37(6):819-33. PubMed ID: 26305688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing nonvitamin K antagonist oral anticoagulants (NOACs) in the laboratory.
    Gosselin RC; Adcock DM
    Int J Lab Hematol; 2015 May; 37 Suppl 1():46-51. PubMed ID: 25976960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results.
    Gosselin RC; Marlar RA
    Semin Thromb Hemost; 2019 Jul; 45(5):433-448. PubMed ID: 31291676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.